Professional
Added to YB: 2024-11-12
Pitch date: 2024-09-30
GALD.SW [bullish]
Galderma Group AG
+128.24%
current return
Author Info
No bio for this author
Company Info
Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology.
Market Cap
CHF 51.7B
Pitch Price
CHF 78.67
Price Target
N/A
Dividend
0.20%
EV/EBITDA
45.87
P/E
85.48
EV/Sales
10.25
Sector
Pharmaceuticals
Category
growth
Artisan Global Discovery Fund Added On Position: Galderma Group
GALD.SW added to position: Leading dermatology co. with strong aesthetics portfolio & $1B+ Cetaphil brand. Expects to outgrow market, expand margins. Nemluvio approval for atopic dermatitis/prurigo nodularis - potential $2B opportunity. Margins to improve as clinical trials end.
Read full article (1 min)